Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effect.

Abstract:

:Evidence from randomized, placebo-controlled, double-masked studies has demonstrated that verteporfin (Visudyne) therapy is effective in reducing the risk of visual acuity loss in selected groups of patients with choroidal neovascularization (CNV) due to age-related macular degeneration (AMD). Pilot studies of intravitreal triamcinolone acetonide monotherapy revealed promising results in patients with CNV due to AMD, but the visual acuity outcomes in a randomized, controlled study were lower than anticipated. Recently, however, there has been growing interest in the adjunctive use of triamcinolone to improve visual acuity and reduce regrowth of CNV in patients receiving verteporfin therapy. This review article surveys the currently available evidence, based on a Medline search covering the years 1980-2005 and abstracts from recent scientific meetings. A number of small-scale, uncontrolled pilot studies have indicated that the combination of triamcinolone acetonide with verteporfin therapy may be beneficial. Evidence is now needed from randomized, controlled studies to determine whether the potential benefits of combination therapy outweigh the possible risks of increased intraocular pressure, endophthalmitis, and progression of cataract that have been observed in trials of triamcinolone monotherapy.

journal_name

Curr Med Res Opin

authors

Kaiser PK

doi

10.1185/030079905X43659

keywords:

subject

Has Abstract

pub_date

2005-05-01 00:00:00

pages

705-13

issue

5

eissn

0300-7995

issn

1473-4877

journal_volume

21

pub_type

杂志文章,评审
  • Reducing coronary risk by raising HDL-cholesterol: risk modelling the addition of nicotinic acid to existing therapy.

    abstract:BACKGROUND AND OBJECTIVES:Reduction in total cholesterol (TC) and LDL-cholesterol (LDL-C) forms one of the principal objectives of most cardiovascular secondary prevention strategies. Many patients being treated with statins, however, have significant residual dyslipidaemia, with many having suboptimal HDL-cholesterol ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007990802374633

    authors: Belsey J,de Lusignan S,van Vlymen J,Chan T,Hague N

    更新日期:2008-09-01 00:00:00

  • Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.

    abstract:OBJECTIVE:Decision aids (DAs) are increasingly used to operationalize shared decision-making (SDM) but their development is not often described. Decisions about oral anticoagulants (OACs) for atrial fibrillation (AF) involve a trade-off between lowering stroke risk and increasing OAC-associated bleeding risk, and consi...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2015.1096767

    authors: Kaiser K,Cheng WY,Jensen S,Clayman ML,Thappa A,Schwiep F,Chawla A,Goldberger JJ,Col N,Schein J

    更新日期:2015-12-01 00:00:00

  • Paramedical students' perceptions of research: a survey.

    abstract:BACKGROUND:There is a general perception that research is underdeveloped in rehabilitation professions. However, a PubMed search found that the growth in publications in the rehabilitation field was twice that of the general medical field. Despite this growth, another study focusing on Europe found that the proportion ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2020.1815685

    authors: Decullier E,Tourmente B,Dessez B,Guilhot N,Witko A

    更新日期:2020-11-01 00:00:00

  • Controlled-release naproxen compared with isoxicam in patients with osteoarthritis.

    abstract::The therapeutic efficacy and tolerability of a new controlled-release 1000 mg tablet of naproxen (naproxen CR) were compared with 200 mg isoxicam in 100 out-patients with osteoarthritis. Medications were administered once daily for 4 weeks in a controlled, randomized, double-blind, parallel trial. Patients were assess...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998809111127

    authors: Frankhof W

    更新日期:1988-01-01 00:00:00

  • A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma.

    abstract:BACKGROUND:Basal cell carcinoma (BCC) is the most common cancer. Most cases of BCCs are treated with only optimal surgical resection. However, unresectable, locally advanced or metastatic tumors might have potential to progress. In this patient group, there is no standardized treatment approach. Vismodegib is a new sel...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2015.1018988

    authors: Erdem GU,Sendur MA,Ozdemir NY,Yazıcı O,Zengin N

    更新日期:2015-04-01 00:00:00

  • Relative bioavailability of a 5 mg mosapride/10 mg rabeprazole fixed dose combination tablet versus separate single tablets in healthy volunteers: a single-dose randomized open-label crossover study.

    abstract:OBJECTIVE:To evaluate the relative bioavailability of a new formulation containing 5 mg mosapride and 10 mg rabeprazole (T) and compare it with the branded formulations of both drugs co-administered in separate tablets (R) to meet the regulatory requirements of bioequivalence in Argentina. METHODS:A randomized-sequenc...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/03007995.2011.624088

    authors: Keller GA,Czerniuk P,Bertuola R,de Mena F,Simoni MV,Assefi AR,Di Girolamo G

    更新日期:2011-11-01 00:00:00

  • Loop diuretics cause less postural hypotension than thiazide diuretics in the frail elderly.

    abstract::Seventy frail elderly patients attending a day hospital were studied to investigate the incidence of postural hypotension in control patients on no diuretic treatment (n = 30), patients on loop diuretics (frusemide) for mild cardiac failure (n = 20) and patients on thiazide diuretics for mild cardiac failure (n = 20)....

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007998809114241

    authors: Heseltine D,Bramble MG

    更新日期:1988-01-01 00:00:00

  • Assessment of the therapeutic activity of a combination of almitrine and raubasine on functional rehabilitation following ischaemic stroke.

    abstract:BACKGROUND AND OBJECTIVES:Stroke is a major cause of disability. Certain experimental studies have suggested that a combination of almitrine + raubasine (Duxil) increases the supply of oxygen to cerebral tissues and may be beneficial in post-stroke rehabilitation. This multicentre clinical study was carried out in orde...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079904125003080

    authors: Li S,Long J,Ma Z,Xu Z,Li J,Zhang Z

    更新日期:2004-03-01 00:00:00

  • Epicardial adipose tissue and atrial fibrillation: pathophysiological mechanisms, clinical implications, and potential therapies.

    abstract:BACKGROUND:Atrial fibrillation (AF) is the most common arrhythmia in clinical practice and is associated with increased cardiovascular morbidity and mortality. Epicardial adipose tissue (EAT) serves as a biologically active organ with important endocrine and inflammatory function. Review An accumulating body of evidenc...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1080/03007995.2018.1462786

    authors: Goudis CA,Vasileiadis IE,Liu T

    更新日期:2018-11-01 00:00:00

  • Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination with amlodipine: a review of factorial-design studies.

    abstract:BACKGROUND:Most patients with hypertension require more than one drug to attain recommended blood pressure (BP) targets. Initiating therapy with two agents is recommended for patients at high risk of a cardiovascular event or with a BP > 20/10 mmHg above goal. Combination therapy is effective when comprised of agents w...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007990802597456

    authors: Ram CV

    更新日期:2009-01-01 00:00:00

  • Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients.

    abstract:OBJECTIVES:We conducted an adjusted comparison of progression-free survival (PFS) and overall survival (OS) for daratumumab monotherapy versus standard of care, as observed in a real-world historical cohort of heavily pretreated multiple myeloma patients from Czech Republic. METHODS:Using longitudinal chart data from ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2017.1410121

    authors: Jelínek T,Maisnar V,Pour L,Špička I,Minařík J,Gregora E,Kessler P,Sýkora M,Fraňková H,Adamová D,Wróbel M,Mikula P,Jarkovský J,Diels J,Gatopoulou X,Veselá Š,Besson H,Brožová L,Ito T,Hájek R

    更新日期:2018-05-01 00:00:00

  • Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience.

    abstract:OBJECTIVE:Osteoarthritis is one of the most common forms of arthritis seen in primary care. Non-steroidal anti-inflammatory drugs (NSAIDs) play an important role in the management of osteoarthritis. However, gastrointestinal (GI) side effects limit their use. Cyclooxygenase-2 (COX-2) selective inhibitors exhibit better...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/030079906X104722

    authors: Pareek A,Chandanwale AS,Oak J,Jain UK,Kapoor S

    更新日期:2006-05-01 00:00:00

  • A comparison of faecal blood loss caused by tenoxicam and piroxicam in normal healthy male volunteers.

    abstract::Faecal blood loss arising from tenoxicam at a dose of 20 mg/day was compared to that arising from piroxicam at a dose of 20 mg/day in a double-blind, parallel comparative study in 12 healthy male volunteers. Faecal blood loss was measured for a 1-week run-in on placebo, during 4 weeks of treatment and for a 2-week pos...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998509109629

    authors: Bird HA,Hill J,Haw WM,Dixon JS,Harris PA,Wright V

    更新日期:1985-01-01 00:00:00

  • Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study.

    abstract:BACKGROUND:Reducing low-density lipoprotein cholesterol (LDL-C) levels to National Cholesterol Expert Panel (NCEP) goal is recommended. However, sex-specific effects may influence benefit. METHODS AND RESULTS:In this post hoc analysis of the GREek Atorvastatin and Coronary heart disease (CHD) Evaluation [GREACE] study...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/03007990802069563

    authors: Athyros VG,Kakafika AI,Papageorgiou AA,Paraskevas KI,Tziomalos K,Anagnostis P,Pagourelias E,Koumaras C,Karagiannis A,Mikhailidis DP

    更新日期:2008-06-01 00:00:00

  • The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients: adaptation of INNOVATE to Sweden.

    abstract:BACKGROUND:Severe allergic asthma patients may not be controlled even with guideline recommended care, including inhaled corticosteroids, long-acting beta-2 agonists, theophylline, oral steroids and anti-leukotrienes. They experience exacerbations requiring intensive healthcare use and which may be fatal. Omalizumab, a...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079906X132389

    authors: Dewilde S,Turk F,Tambour M,Sandström T

    更新日期:2006-09-01 00:00:00

  • New centrally acting agents for appetite control: from biological mechanisms to clinical efficacy.

    abstract:BACKGROUND:Obesity is one of the major problems of health policy in different countries. Pharmacological attempts have been made to help affected people without a definitive solution. Some agents--either with peripheral or central effect--are available in the market. On July 2012, the FDA approved two novel preparation...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2014.884494

    authors: Catoira NP,Viale L,Di Girolamo G,Gonzalez C

    更新日期:2014-06-01 00:00:00

  • Current strategies in the management of hypereosinophilic syndrome, including mepolizumab.

    abstract:BACKGROUND:Patients with hypereosinophilic syndrome (HES) vary considerably in their clinical presentation with regard to the severity and pattern of end-organ involvement. Clinical manifestations range from nonspecific symptoms to life-threatening, multisystem damage caused by eosinophil infiltration and local release...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2010.493132

    authors: Schwartz LB,Sheikh J,Singh A

    更新日期:2010-08-01 00:00:00

  • Effect of gliclazide modified release on adiponectin, interleukin-6, and tumor necrosis factor-alpha plasma levels in individuals with type 2 diabetes mellitus.

    abstract:OBJECTIVE:The aim of the study was to evaluate the effect of gliclazide modified release (MR) treatment on adiponectin, interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) plasma concentrations in type 2 diabetic patients. RESEARCH DESIGN AND METHODS:24 randomly selected type 2 diabetic patients, aged 61...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/030079906X132424

    authors: Drzewoski J,Zurawska-Klis M

    更新日期:2006-10-01 00:00:00

  • Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.

    abstract:OBJECTIVE:Neuropathic pain is often difficult to treat due to a complex pathophysiology. This study evaluated the efficacy, tolerability and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin for neuropathic pain in patients with post-herpetic neuralgia (PHN) or painful diabetic polyneurop...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1185/03007990903048078

    authors: Baron R,Mayoral V,Leijon G,Binder A,Steigerwald I,Serpell M

    更新日期:2009-07-01 00:00:00

  • Preliminary evaluation of a new controlled-release oxybutynin in urinary incontinence.

    abstract:OBJECTIVE:To conduct a preliminary evaluation of a new oral formulation of controlled-release (CR) oxybutynin tablet taken once-daily in patients with urinary urge incontinence. RESEARCH DESIGN AND METHODS:A single-centre, open-label, 8-week study was conducted. Patients with urodynamically-confirmed detrusor instabil...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/030079903125002955

    authors: Radomski SB,Caley B,Reiz JL,Miceli PC,Harsanyi Z,Darke AC

    更新日期:2004-01-01 00:00:00

  • A novel application for bolus remifentanil: blunting the hemodynamic response to Mayfield skull clamp placement.

    abstract:OBJECTIVE:Neurosurgery often requires skull immobilization with a Mayfield clamp, which often causes brief intense nociceptive stimulation, hypertension and tachycardia. Blunting this response may help prevent increased intracranial pressure, cerebral aneurysm or vascular malformation rupture, and/or myocardial stress....

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2013.855190

    authors: Berger M,Philips-Bute B,Guercio J,Hopkins TJ,James ML,Borel CO,Warner DS,McDonagh DL

    更新日期:2014-02-01 00:00:00

  • Brentuximab vedotin compared with other therapies in relapsed/refractory Hodgkin lymphoma post autologous stem cell transplant: median overall survival meta-analysis.

    abstract:OBJECTIVE:This meta-analysis compared the median overall survival (mOS) of brentuximab vedotin reported in the pivotal phase 2 study with published results of other therapies for the treatment of relapsed/refractory (R/R) Hodgkin lymphoma (HL) post autologous stem cell transplant (ASCT). RESEARCH DESIGN AND METHODS:A ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析

    doi:10.1185/03007995.2015.1048208

    authors: Bonthapally V,Yang H,Ayyagari R,Tan RD,Cai S,Wu E,Gautam A,Chi A,Huebner D

    更新日期:2015-01-01 00:00:00

  • Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis.

    abstract:BACKGROUND:As results from an increasing number of clinical trials with disease-modifying drugs (DMDs) in multiple sclerosis (MS) become available, the challenge for the treating neurologist is how to decide on the appropriate therapy for an individual patient. OBJECTIVE:An International Working Group for Treatment Op...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007x233007

    authors: Goodin DS,Biermann LD,Bohlega S,Boiko A,Chofflon M,Gebeily S,Gouider R,Havrdova E,Jakab G,Karabudak R,Karussis D,Miller A,Pakdaman H,Selmaj K,Sharief M,International Working Group for Treatment Optimization in MS.

    更新日期:2007-11-01 00:00:00

  • Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.

    abstract:OBJECTIVE:To compare safety and efficacy of biphasic insulin aspart 70/30 (BIAsp 30) with exenatide in subjects with type 2 diabetes mellitus (T2DM) not achieving glycemic targets with metformin and sulfonylurea in a randomized, open-label, 24-week trial. RESEARCH DESIGN AND METHODS:Subjects (N = 372, T2DM > 6 months,...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/03007990802597951

    authors: Bergenstal R,Lewin A,Bailey T,Chang D,Gylvin T,Roberts V,NovoLog Mix-vs.-Exenatide Study Group.

    更新日期:2009-01-01 00:00:00

  • Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study.

    abstract:OBJECTIVE:To compare the analgesic efficacy and safety of oxymorphone extended release (ER) and oxycodone controlled release (CR) in patients with moderate to severe cancer pain. RESEARCH DESIGN AND METHODS:This randomized, multicenter, double-blind, 2-period crossover study included adult outpatients (>or= 18 years o...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079904125003854

    authors: Gabrail NY,Dvergsten C,Ahdieh H

    更新日期:2004-06-01 00:00:00

  • Statin treatment patterns and clinical profile of patients with risk factors for coronary heart disease defined by National Cholesterol Education Program Adult Treatment Panel III.

    abstract:OBJECTIVE:To compare clinical characteristics, statin treatment patterns and adherence among patients at different risk for coronary heart disease (CHD) as defined by National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III guidelines. METHODS:Patients ≥ 18 years old with ≥ 1 claim for dyslipidemi...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2014.971151

    authors: Kern DM,Balu S,Tunceli O,Anzalone D

    更新日期:2014-12-01 00:00:00

  • Emergency department visits for gastrointestinal bleeding in children: results from the Nationwide Emergency Department Sample 2006-2011.

    abstract:OBJECTIVE:To describe the epidemiology and trends in pediatric gastrointestinal (GI) bleeding associated emergency department (ED) visits in the US. METHODS:Estimates of GI bleeding associated ED visits were calculated in children from birth to 19 years of age using the Nationwide Emergency Department Sample (NEDS). ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2014.986569

    authors: Pant C,Olyaee M,Sferra TJ,Gilroy R,Almadhoun O,Deshpande A

    更新日期:2015-02-01 00:00:00

  • Impact of new Joint British Societies' (JBS 2) guidelines on prevention of cardiovascular disease: evaluation of serum total cholesterol goal achievement in UK clinical practice.

    abstract:BACKGROUND:Consensus health panels, including the Joint British Societies (JBS), have established increasingly stringent cholesterol goals. However, in clinical settings, most patients do not achieve even the less stringent goals. OBJECTIVE:To provide descriptive data on the proportion of patients in the United Kingdo...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,实务指引

    doi:10.1185/030079907X219472

    authors: Rajagopalan S,Alemao E,Finch L,Yin D

    更新日期:2007-08-01 00:00:00

  • Pathfinding to an optimal strategy of revascularization in primary coronary intervention in patients with multivessel disease: a network meta-analysis of randomized trials.

    abstract:OBJECTIVES:In ST-segment elevation myocardial infarction (STEMI), current guidelines discourage treatment of the non-culprit lesions at the time of the primary intervention. Latest trials have challenged this strategy suggesting benefit of early complete revascularization. We performed a Bayesian multiple treatment net...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2016.1260534

    authors: Komócsi A,Kehl D,d'Ascenso F,DiNicolantonio J,Vorobcsuk A

    更新日期:2017-03-01 00:00:00

  • Sleep and wake after benzodiazepine hypnotics: a 20-hour EEG comparison of lormetazepam and flunitrazepam.

    abstract::In an electropharmacokinetic study, the effects of lormetazepam and flunitrazepam were compared by the means of a sleep EEG and waking EEG during the following daytime. At a 1-week interval, 6 normal subjects received at random either 2 mg lormetazepam or 2 mg flunitrazepam in a double-blind, crossover fashion. Sleep ...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998509109634

    authors: Timsit-Berthier M,de Thier D,Machowsky R,Mantanus H,Rousseau JC

    更新日期:1985-01-01 00:00:00